Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity
- PMID: 10445400
- DOI: 10.1016/S0940-2993(99)80024-4
Homology modelling of human cytochromes P450 involved in xenobiotic metabolism and rationalization of substrate selectivity
Abstract
Molecular modelling of human cytochrome P450 (CYP) isoforms is described, based on amino acid sequence homology with a unique bacterial P450 (CYP102) of known crystal structure. It is found that for the human hepatic P450s involved in the metabolism of xenobiotics, ie. CYPIA2, CYP 1A6, CYP2B6, CYP2C9, CYP2C 19, CYP2D6, CYP2E1 and CYP3A4, there is a satisfactory agreement between specific substrate characteristics and topographical features of the putative active sites, including complementarity with key amino acid residues in the P450 haem environments. A combination of homology model interactions with substrates and certain molecular properties of the compounds themselves provides a methodology for the evaluation of potential P450 selectivity in new chemical entities (NCEs).
Similar articles
-
Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure.Xenobiotica. 2002 Apr;32(4):305-23. doi: 10.1080/00498250110112015. Xenobiotica. 2002. PMID: 12028664
-
Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.Arch Biochem Biophys. 2003 Jan 1;409(1):32-44. doi: 10.1016/s0003-9861(02)00349-1. Arch Biochem Biophys. 2003. PMID: 12464242
-
Human cytochrome P450s: selectivity and measurement in vivo.Xenobiotica. 1998 Dec;28(12):1095-128. doi: 10.1080/004982598238859. Xenobiotica. 1998. PMID: 9890156 Review. No abstract available.
-
Gemfibrozil is a potent inhibitor of human cytochrome P450 2C9.Drug Metab Dispos. 2001 Nov;29(11):1359-61. Drug Metab Dispos. 2001. PMID: 11602509
-
Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.Biochem Biophys Res Commun. 2005 Dec 9;338(1):331-6. doi: 10.1016/j.bbrc.2005.08.190. Epub 2005 Sep 2. Biochem Biophys Res Commun. 2005. PMID: 16157296 Review.
Cited by
-
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).Pharm Res. 2015 Dec;32(12):3785-802. doi: 10.1007/s11095-015-1749-4. Epub 2015 Jul 9. Pharm Res. 2015. PMID: 26155985
-
Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions.Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S82-9. doi: 10.1038/sj.bjp.0707570. Epub 2007 Nov 19. Br J Pharmacol. 2008. PMID: 18026129 Free PMC article. Review.
-
The Development and Validation of a Novel "Dual Cocktail" Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions.Pharmaceutics. 2020 Sep 30;12(10):938. doi: 10.3390/pharmaceutics12100938. Pharmaceutics. 2020. PMID: 33007943 Free PMC article.
-
Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells.Br J Pharmacol. 2002 Jun;136(3):347-52. doi: 10.1038/sj.bjp.0704711. Br J Pharmacol. 2002. PMID: 12023936 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources